Armstrong Flooring, Inc. (NYSE:AFI) boasts a Price to Book ratio of 0.780788. This ratio is calculated by dividing the current share price by the book value per share. Investors may use Price to Book to display how the market portrays the value of a stock. Checking in on some other ratios, the company has a Price to Cash Flow ratio of 79.682635, and a current Price to Earnings ratio of -1.741439. The P/E ratio is one of the most common ratios used for figuring out whether a company is overvalued or undervalued.

New investors may be trying to figure out the best way to build a solid foundation with which to make future investing decisions. There are many different paths that an investor can take once they become familiar with the territory. Some investors will choose to study professional analyst research and recommendations. This can be very useful, but many investors may feel more comfortable doing their own research. Conducting stock research may involve looking at the fundamentals of a certain company. Understanding what kind of competitive advantage a company might have compared to others in their industry may help weed out some of the more undesirable stocks. Because there is no one way to properly conduct stock research, investors may need to try a few different methods in order to determine the best individual course of action.

Armstrong Flooring, Inc. (NYSE:AFI) has a current MF Rank of 13305. Developed by hedge fund manager Joel Greenblatt, the intention of the formula is to spot high quality companies that are trading at an attractive price. The formula uses ROIC and earnings yield ratios to find quality, undervalued stocks. In general, companies with the lowest combined rank may be the higher quality picks.

There are many different tools to determine whether a company is profitable or not. One of the most popular ratios is the “Return on Assets” (aka ROA). This score indicates how profitable a company is relative to its total assets. The Return on Assets for Armstrong Flooring, Inc. (NYSE:AFI) is -0.193907. This number is calculated by dividing net income after tax by the company’s total assets. A company that manages their assets well will have a higher return, while a company that manages their assets poorly will have a lower return.

The Piotroski F-Score is a scoring system between 1-9 that determines a firm’s financial strength. The score helps determine if a company’s stock is valuable or not. The Piotroski F-Score of Armstrong Flooring, Inc. (NYSE:AFI) is 4. A score of nine indicates a high value stock, while a score of one indicates a low value stock. The score is calculated by the return on assets (ROA), Cash flow return on assets (CFROA), change in return of assets, and quality of earnings. It is also calculated by a change in gearing or leverage, liquidity, and change in shares in issue. The score is also determined by change in gross margin and change in asset turnover.

Further, we can see that Armstrong Flooring, Inc. (NYSE:AFI) has a Shareholder Yield of -0.003301 and a Shareholder Yield (Mebane Faber) of 0.01664. The first value is calculated by adding the dividend yield to the percentage of repurchased shares. The second value adds in the net debt repaid yield to the calculation. Shareholder yield has the ability to show how much money the firm is giving back to shareholders via a few different avenues. Companies may issue new shares and buy back their own shares. This may occur at the same time. Investors may also use shareholder yield to gauge a baseline rate of return.

**Volatility/PI**

Stock volatility is a percentage that indicates whether a stock is a desirable purchase. Investors look at the Volatility 12m to determine if a company has a low volatility percentage or not over the course of a year. The Volatility 12m of Armstrong Flooring, Inc. (NYSE:AFI) is 50.826000. This is calculated by taking weekly log normal returns and standard deviation of the share price over one year annualized. The lower the number, a company is thought to have low volatility. The Volatility 3m is a similar percentage determined by the daily log normal returns and standard deviation of the share price over 3 months. The Volatility 3m of Armstrong Flooring, Inc. (NYSE:AFI) is 47.747200. The Volatility 6m is the same, except measured over the course of six months. The Volatility 6m is 44.180200.

The Price Index is a ratio that indicates the return of a share price over a past period. The price index of Armstrong Flooring, Inc. (NYSE:AFI) for last month was 1.03864. This is calculated by taking the current share price and dividing by the share price one month ago. If the ratio is greater than 1, then that means there has been an increase in price over the month. If the ratio is less than 1, then we can determine that there has been a decrease in price. Similarly, investors look up the share price over 12 month periods. The Price Index 12m for Armstrong Flooring, Inc. (NYSE:AFI) is 0.80932.

Checking in on some valuation rankings, Armstrong Flooring, Inc. (NYSE:AFI) has a Value Composite score of 39. Developed by James O’Shaughnessy, the VC score uses five valuation ratios. These ratios are price to earnings, price to cash flow, EBITDA to EV, price to book value, and price to sales. The VC is displayed as a number between 1 and 100. In general, a company with a score closer to 0 would be seen as undervalued, and a score closer to 100 would indicate an overvalued company. Adding a sixth ratio, shareholder yield, we can view the Value Composite 2 score which is currently sitting at 46.

Investors may be interested in viewing the Gross Margin score on shares of Armstrong Flooring, Inc. (NYSE:AFI). The name currently has a score of 25.00000. This score is derived from the Gross Margin (Marx) stability and growth over the previous eight years. The Gross Margin score lands on a scale from 1 to 100 where a score of 1 would be considered positive, and a score of 100 would be seen as negative.

Investors might be trying to figure out the best way to approach the stock market. After creating a plan that includes a list of stocks to purchase, investors may be looking to gauge the best time to enter the trade. With markets still cruising along at high altitudes, investors may be worried about buying at the top. Most individuals would probably agree that getting out before the market drops would be the best play. Obviously this is much easier said than done. If the warning signs were blatant, everyone would know exactly when to sell and when to re-buy. When the stock market has a big decline, the natural instinct is generally to sell in order to protect gains or eliminate further losses. Trying to time the market can have negative implications for investors who are not prepared to handle extremely volatile market conditions. Being prepared for any sudden change in the overall economy or stock market conditions may help the investor stay afloat for the long haul.

Eiger BioPharmaceuticals, Inc. (NasdaqGM:EIGR) has a Price to Book ratio of 4.843034. This ratio has been calculated by dividing the current share price by the book value per share. Investors may use Price to Book to display how the market portrays the value of a stock. Checking in on some other ratios, the company has a Price to Cash Flow ratio of -4.644399, and a current Price to Earnings ratio of -4.050517. The P/E ratio is one of the most common ratios used for figuring out whether a company is overvalued or undervalued.

Many investors pay close attention to historical price movements when analyzing stocks. They may also take a deeper look into which sectors have been the best performers over the same time frame. Everyone seems to have an opinion on which way the market will move in the near-term. With the stock market still moving higher, many stock picks may still look really good. Reviewing specific stocks in the portfolio may help scout out the ones that may only be higher because of overall market levels. Predicting the next market shift is usually near impossible. Having the right stocks in the portfolio can help ease the investor’s mind no matter what the next few months brings in terms of volatility.

Further, we can see that Eiger BioPharmaceuticals, Inc. (NasdaqGM:EIGR) has a Shareholder Yield of -0.825021 and a Shareholder Yield (Mebane Faber) of -0.84688. The first value is calculated by adding the dividend yield to the percentage of repurchased shares. The second value adds in the net debt repaid yield to the calculation. Shareholder yield has the ability to show how much money the firm is giving back to shareholders via a few different avenues. Companies may issue new shares and buy back their own shares. This may occur at the same time. Investors may also use shareholder yield to gauge a baseline rate of return.

Checking in on some valuation rankings, Eiger BioPharmaceuticals, Inc. (NasdaqGM:EIGR) has a Value Composite score of 89. Developed by James O’Shaughnessy, the VC score uses five valuation ratios. These ratios are price to earnings, price to cash flow, EBITDA to EV, price to book value, and price to sales. The VC is displayed as a number between 1 and 100. In general, a company with a score closer to 0 would be seen as undervalued, and a score closer to 100 would indicate an overvalued company. Adding a sixth ratio, shareholder yield, we can view the Value Composite 2 score which is currently sitting at 93.

Eiger BioPharmaceuticals, Inc. (NasdaqGM:EIGR) has a current MF Rank of 18011. Developed by hedge fund manager Joel Greenblatt, the intention of the formula is to spot high quality companies that are trading at an attractive price. The formula uses ROIC and earnings yield ratios to find quality, undervalued stocks. In general, companies with the lowest combined rank may be the higher quality picks.

There are many different tools to determine whether a company is profitable or not. One of the most popular ratios is the “Return on Assets” (aka ROA). This score indicates how profitable a company is relative to its total assets. The Return on Assets for Eiger BioPharmaceuticals, Inc. (NasdaqGM:EIGR) is -1.775197. This number is calculated by dividing net income after tax by the company’s total assets. A company that manages their assets well will have a higher return, while a company that manages their assets poorly will have a lower return.

The Piotroski F-Score is a scoring system between 1-9 that determines a firm’s financial strength. The score helps determine if a company’s stock is valuable or not. The Piotroski F-Score of Eiger BioPharmaceuticals, Inc. (NasdaqGM:EIGR) is 2. A score of nine indicates a high value stock, while a score of one indicates a low value stock. The score is calculated by the return on assets (ROA), Cash flow return on assets (CFROA), change in return of assets, and quality of earnings. It is also calculated by a change in gearing or leverage, liquidity, and change in shares in issue. The score is also determined by change in gross margin and change in asset turnover.

**Volatility/PI**

Stock volatility is a percentage that indicates whether a stock is a desirable purchase. Investors look at the Volatility 12m to determine if a company has a low volatility percentage or not over the course of a year. The Volatility 12m of Eiger BioPharmaceuticals, Inc. (NasdaqGM:EIGR) is 59.878800. This is calculated by taking weekly log normal returns and standard deviation of the share price over one year annualized. The lower the number, a company is thought to have low volatility. The Volatility 3m is a similar percentage determined by the daily log normal returns and standard deviation of the share price over 3 months. The Volatility 3m of Eiger BioPharmaceuticals, Inc. (NasdaqGM:EIGR) is 53.377700. The Volatility 6m is the same, except measured over the course of six months. The Volatility 6m is 51.398100.

The Price Index is a ratio that indicates the return of a share price over a past period. The price index of Eiger BioPharmaceuticals, Inc. (NasdaqGM:EIGR) for last month was 0.92555. This is calculated by taking the current share price and dividing by the share price one month ago. If the ratio is greater than 1, then that means there has been an increase in price over the month. If the ratio is less than 1, then we can determine that there has been a decrease in price. Similarly, investors look up the share price over 12 month periods. The Price Index 12m for Eiger BioPharmaceuticals, Inc. (NasdaqGM:EIGR) is 0.66910.

Investors may be interested in viewing the Gross Margin score on shares of Eiger BioPharmaceuticals, Inc. (NasdaqGM:EIGR). The name currently has a score of 50.00000. This score is derived from the Gross Margin (Marx) stability and growth over the previous eight years. The Gross Margin score lands on a scale from 1 to 100 where a score of 1 would be considered positive, and a score of 100 would be seen as negative.

New investors may be trying to figure out the best way to build a solid foundation with which to make future investing decisions. There are many different paths that an investor can take once they become familiar with the territory. Some investors will choose to study professional analyst research and recommendations. This can be very useful, but many investors may feel more comfortable doing their own research. Conducting stock research may involve looking at the fundamentals of a certain company. Understanding what kind of competitive advantage a company might have compared to others in their industry may help weed out some of the more undesirable stocks. Because there is no one way to properly conduct stock research, investors may need to try a few different methods in order to determine the best individual course of action.